Related Experiment Videos
Disseminated intravascular and intracardiac thrombosis after cardiopulmonary bypass
Deepak K Tempe1, Parin Lalwani1, Kapil Chaudhary1
1Department of Anaesthesiology and Intensive Care, G B Pant Institute of Postgraduate Medical Education and Research and Associated Maulana Azad Medical College, New Delhi, India.
Insights
Massive thrombosis after cardiopulmonary bypass (CPB) is rare. This case study details disseminated intravascular and intracardiac thrombosis following mitral valve replacement, even without antifibrinolytic agents, offering insights into pathophysiology and management.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Hematology
Background:
- Massive intracardiac and intravascular thrombosis is a rare but serious complication after cardiopulmonary bypass (CPB).
- Previous reports primarily linked disseminated thrombosis to complex cardiac surgeries or the use of antifibrinolytic agents during CPB.
- The occurrence of such thrombosis in simpler procedures without antifibrinolytics remains less understood.
Abstract:
Massive intracardiac and intravascular thrombosis is a rare complication following cardiopulmonary bypass (CPB). Most of the cases of the disseminated thrombosis have been reported in patients undergoing complex cardiac surgeries and those receiving antifibrinolytic agents during CPB. We report the occurrence of disseminated intravascular and intracardiac thrombosis after CPB in a patient undergoing mitral valve replacement in which no antifibrinolytic agent was used. The possible pathophysiology and management of the patient is discussed.